FY2025 · ended Dec 31, 2025 · Revenue $11.42M, +31.5% YoY · Filed Mar 31, 2026
Nexgel, Inc. (NXGL) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $11.4 million and a net loss of $3.0 million. Free cash flow was -$1.4 million. As of Jun 30, 2026 it held $492,000 in cash and investments and $3.9 million in total debt.
Revenue (TTM)
$12.07M
+3.4% vs year-ago TTM
Net income (TTM)
$-6.19M
-111.8% vs year-ago TTM
Operating cash flow (TTM)
$-3.21M
-11.2% vs year-ago TTM
Free cash flow
$-1.38M
+68.0% vs prior year
EPS (TTM)
$-0.75
-86.3% vs year-ago TTM
Dividend per share
None
Shares outstanding
8.85M
+4.4% vs prior year
Net cash
$-3.38M
as of Jun 30, 2026
Operating margin
-44.8%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- NXGL (Nasdaq), NXGLW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Langhorne, PA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1468929
- Former names
- NEXGEL, INC. (until Oct 7, 2026); AquaMed Technologies, Inc. (until Nov 14, 2019)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $11.4M | $8.7M | $4.1M | $2.0M | $1.6M |
| Operating income | -$3.4M | -$3.6M | -$3.5M | -$3.3M | -$2.6M |
| Net income | -$3.0M | -$3.3M | -$3.2M | -$4.7M | -$4.3M |
| Diluted EPS | -$0.38 | -$0.50 | -$0.56 | — | -$1.45 |
| Operating cash flow | -$1.3M | -$3.9M | -$3.2M | -$3.0M | -$2.8M |
| Free cash flow | -$1.4M | -$4.3M | -$3.9M | -$3.1M | -$3.0M |
| Total assets | $10.5M | $11.0M | $10.0M | $10.4M | $17.0M |
| Total liabilities | $5.6M | $4.9M | $4.8M | $2.7M | $4.9M |
| Stockholders' equity | $4.5M | $5.8M | $4.7M | $7.6M | $12.1M |
| Cash and investments | $317,000 | $1.8M | $2.7M | $6.6M | $13.3M |
| Total debt | $3.1M | $2.8M | $2.8M | $2.1M | $2.0M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Oct 7, 2026 | Oct 7, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 24, 2026 | Sep 24, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Sep 23, 2026 | Sep 23, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 21, 2026 | Aug 21, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 17, 2026 | Aug 17, 2026 |
| 10-Q | Quarterly report | Aug 17, 2026 | Jun 30, 2026 |
All 327 Nexgel, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.